Activating Compound | Comment | Organism | Structure |
---|---|---|---|
phorbol myristate acetate | PMA, 100 nM to cells induces translocation (maximum after 15 min) of enzyme to the Golgi apparatus and release of 4-5% of cell-associated arachidonic acid within 80 min, effect impaired by PKC inhibition and block of protein synthesis | Mus musculus | |
serum | 10% mouse serum to cells induces immediate translocation (within 60 seconds) of enzyme to the Golgi apparatus and release of 20% of cell-associated arachidonic acid within 80 min, effect depends on ERK and p38/MAPK pathway activation and calcium binding, effect is impaired by block of protein synthesis | Mus musculus |
Cloned (Comment) | Organism |
---|---|
together with EGFP cDNA in AdEasy vector or together with monomeric EYFP or ECFP cDNA in pVQAd5CMVK-NpA shuttle plasmid for adenovirus-mediated infection of lung fibroblasts | Mus musculus |
Protein Variants | Comment | Organism |
---|---|---|
K271N/K273N/K274N | wild-type activity, half the wild-type increase in activity in presence of phosphatidylinositol 4,5-biphosphate | Mus musculus |
K43N | impaired release of arachidonic acid in response to serum and phorbol myristate acetate, no translocation to Golgi apparatus in response to serum, C2-domain mutant, calcium and membrane binding | Mus musculus |
K488N/K543N/K544N | 2fold increased specific activity (independent of phosphatidylinositol 4,5-biphosphate), 78% reduced release of arachidonic acid and increased Golgi-binding in response to serum, PIP2-binding site triple mutant | Mus musculus |
K541N/K543N/K544N | 2fold increased specific activity (independent of phosphatidylinositol 4,5-biphosphate) | Mus musculus |
S505A | 38% reduced release of arachidonic acid and prolonged accumulation at Golgi apparatus in response to serum and 30% reduced release of arachidonic acid in response to phorbol myristate acetate, phosphorylation site mutant | Mus musculus |
S505A/S727A | 30% reduced release of arachidonic acid in response to phorbol myristate acetate and 50% in response to serum which is further reduced by ERK inhibition, prolonged accumulation at Golgi apparatus in response to serum, phosphorylation site double mutant | Mus musculus |
S505A/S727A/S515A | similar response to serum as double mutant S505A/S727A, phosphorylation site triple mutant | Mus musculus |
S515A | phosphorylation site mutant | Mus musculus |
S727A | similar release of arachidonic acid in response to serum like wild-type enzyme, phosphorylation site mutant | Mus musculus |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
Golgi apparatus | transient serum-induced translocation of EGFP-tagged enzyme (7%) in parallel to sharp increase in intracellular calcium (within initial 60 seconds), stable binding dependent on influx of extracellular calcium induced here by phorbol myristate acetate | Mus musculus | 5794 | - |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
Ca2+ | 50% of maximal activation at 0.7 +/-0.1 microM (independent of presence of 10 mol% phosphatidylinositol 4,5-biphosphate), 12% less activity in absence of calcium | Mus musculus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Mus musculus | - |
wild-type or homozygous knockout mice | - |
Posttranslational Modification | Comment | Organism |
---|---|---|
phosphoprotein | phosphorylation at S505 increases activity 2fold, phosphorylation state not influenced by serum or phorbol myristate acetate, no impact on calcium-mediated membrane binding, constitutively phosphorylated at S505 in immortalized cells (SV40 transformed) | Mus musculus |
Purification (Comment) | Organism |
---|---|
following expression with C-terminal hexa-His-tag, dephosphorylation with potato acid phosphatase | Mus musculus |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
blood platelet | activated | Mus musculus | - |
lung fibroblast | isolated from wild-type or knockout mice, subsequently SV40 transformed | Mus musculus | - |
Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|
additional information | - |
5fold increase in specific activity of activated platelet-derived wild-type and phosphorylated forms in presence of 10 mol% phosphatidylinositol 4,5-biphosphate | Mus musculus |
0.21 | - |
mutant K271N/K273N/K274N, from activated platelets | Mus musculus |
0.23 | - |
wild-type, from activated platelets | Mus musculus |
0.26 | - |
phoshorylated at residue S515, from activated platelets | Mus musculus |
0.38 | - |
phoshorylated at residue S505, from activated platelets | Mus musculus |
0.39 | - |
mutant K488N/K543N/K544N, from activated platelets, in presence of 10 mol% phosphatidylinositol 4,5-biphosphate | Mus musculus |
0.4 | - |
mutant K488N/K543N/K544N, from activated platelets | Mus musculus |
0.405 | - |
phosphorylated at residues S505 and S727, from activated platelets | Mus musculus |
0.68 | - |
mutant K271N/K273N/K274N, from activated platelets, in presence of 10 mol% phosphatidylinositol 4,5-biphosphate | Mus musculus |
0.866 | - |
phoshorylated at residue S515, from activated platelets, in presence of 10 mol% phosphatidylinositol 4,5-biphosphate | Mus musculus |
1.03 | - |
wild-type, from activated platelets, in presence of 10 mol% phosphatidylinositol 4,5-biphosphate | Mus musculus |
1.45 | - |
phoshorylated at residue S505, from activated platelets, in presence of 10 mol% phosphatidylinositol 4,5-biphosphate | Mus musculus |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphocholine + H2O | 2 min, 37°C (pre-warmed), in presence of 0.5 mg/ml bovine serum albumin and various concentrations of calcium | Mus musculus | arachidonic acid + 1-palmitoyl-sn-glycero-3-phosphocholine | quantification of release of radio-labelled arachidonic acid | ? |
Synonyms | Comment | Organism |
---|---|---|
cPLA2alpha | - |
Mus musculus |
group IVA cytosolic phospholipase A2alpha | - |
Mus musculus |